MedPath

Serum Hs-CRP in Periodontitis Patients With or Without Diabetes

Not Applicable
Completed
Conditions
Periodontal Disease
Diabetes Mellitus, Type 2
Registration Number
NCT03908606
Lead Sponsor
Cairo University
Brief Summary

the aim of this study was to assess serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy.

Detailed Description

Periodontitis and diabetes are chronic disorders with a two-way correlation as they can both stimulate an inflammatory response with subsequent formation of inflammatory mediators and cytokines. C reactive protein is an inflammatory plasma marker having a role in the systemic reaction to inflammation. thus, our aim in the current study was to evaluate serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy. A total of 60 patients were enrolled in this study. ELISA was used for determination of hs- CRP. Non- surgical periodontal therapy was carried out for all periodontitis patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Diabetic patients type 2
  2. Periodontitis patients
Exclusion Criteria
  1. Smokers
  2. Pregnant females

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
clinical attachment level3 months

gain in clinical attachment level

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cairo University

🇪🇬

Cairo, Egypt

Cairo University
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.